Literature DB >> 6948313

Urinary MAO inhibitor in psychiatric illness.

H Petursson, M A Reveley, V Glover, M Sandler.   

Abstract

Normal human urine contains an endogenous monoamine oxidase inhibitor. We have now investigated its activity in urine samples from psychiatric patients in various diagnostic categories. Significantly higher values were observed in alcoholics recently withdrawn from ethanol, compared with controls. Inhibitory activity was not specifically related to primary affective disorders. Inhibitor output may be positively related to certain symptom clusters rather than to disease entities (i.e. alcohol withdrawal, agitation, and hyperkinesis). Significantly lower inhibitor output was also found in a small group of patients with chronic schizophrenia.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6948313     DOI: 10.1016/0165-1781(81)90081-0

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  5 in total

1.  Urinary output of endogenous monoamine oxidase inhibitor and isatin during acute migraine attacks.

Authors:  J Jarman; A Przyborowska; V Glover; J Halket; P T Davies; F C Rose; M Sandler
Journal:  J Neural Transm Gen Sect       Date:  1991

2.  Tribulin output in neurological disorders.

Authors:  A Clow; V Glover; M Sandler; R Elwes; E H Reynolds
Journal:  Br J Clin Pharmacol       Date:  1987-09       Impact factor: 4.335

3.  Output of endogenous monoamine oxidase inhibitor in rats: effect of ethanol, tryptamine and tryptophan.

Authors:  I Armando; V Glover; M Sandler; S E File
Journal:  J Neural Transm       Date:  1983       Impact factor: 3.575

4.  Increased urinary tribulin output in generalised anxiety disorder.

Authors:  A Clow; V Glover; M Sandler; J Tiller
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

5.  beta-Carbolines as selective monoamine oxidase inhibitors: in vivo implications.

Authors:  V Glover; J Liebowitz; I Armando; M Sandler
Journal:  J Neural Transm       Date:  1982       Impact factor: 3.575

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.